Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

963
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
963
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

192
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
192
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

723
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
723
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

73
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
73
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

8.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effects of Adenosine A1/A3 Receptors Agonist on Improving the Outcomes of TBI and Stroke: Focus on AST-004.

Current neurology and neuroscience reports·2026
Same author

Is early thrombectomy of proximal middle cerebral artery occlusion to salvage internal capsule associated with improved clinical outcomes?

Frontiers in stroke·2026
Same author

Imaging Factors Associated With Poor Outcome in Patients With Basilar Artery Occlusion Treated With Endovascular Thrombectomy.

Stroke (Hoboken, N.J.)·2026
Same author

Safety of Intravenous Cangrelor Versus Dual Oral Antiplatelet Loading Therapy in Endovascular Treatment of Tandem Lesions: An Observational Cohort Study.

Stroke (Hoboken, N.J.)·2026
Same author

Effect of the Cervical Lesion Severity on Procedural and Clinical Outcomes after Endovascular Treatment of Acute Tandem Lesions: A Multicenter Study.

Stroke (Hoboken, N.J.)·2026
Same author

Time-Dependent Efficacy of Drag-Reducing Polymers in the Treatment of Permanent Middle Cerebral Artery Occlusion Injury in Rats.

Advances in experimental medicine and biology·2026

Related Experiment Video

Updated: Jul 12, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
09:14

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

2.4K

Neurological Complications Associated with Hereditary Bleeding Disorders.

Muhammad Qasim Bhatti1, Ezekiel Gonzalez-Fernandez1, Kunal Bhatia1

  • 1Department of Neurology, University of Mississippi Medical Center, Jackson, MS, USA.

Current Neurology and Neuroscience Reports
|October 21, 2023
PubMed
Summary

Hereditary bleeding disorders like hemophilia and von Willebrand disease can cause severe central nervous system (CNS) bleeding. Effective management involves factor replacement, risk factor identification, and optimal coagulant levels to prevent intracranial hemorrhage (ICH).

Keywords:
Bleeding disordersHemophiliaIntracranial hemorrhageNeurological complicationsvon Willebrand diseasevon Willebrand factor

More Related Videos

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

10.4K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

786

Related Experiment Videos

Last Updated: Jul 12, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
09:14

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

2.4K
Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

10.4K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

786

Area of Science:

  • Neurology
  • Hematology
  • Genetics

Background:

  • Hereditary bleeding disorders present with diverse clinical symptoms, from mild bleeding to severe central nervous system (CNS) complications.
  • Intracranial hemorrhage (ICH) is the most feared complication, significantly increasing morbidity and mortality in patients with hemophilia.

Purpose of the Study:

  • To review the pathophysiology and clinical manifestations of hemophilia A, hemophilia B, and von Willebrand disease (vWD).
  • To emphasize neurological complications, including ICH, and discuss current management strategies.
  • To review literature guiding treatment for CNS bleeding in these disorders.

Main Methods:

  • Literature review of hereditary bleeding disorders, focusing on neurological complications.
  • Analysis of management strategies for CNS bleeding in hemophilia and vWD.
  • Evaluation of recent advancements, including Emicizumab therapy.

Main Results:

  • ICH is a major cause of mortality in hemophilia patients; optimal factor management is crucial.
  • Emicizumab has transformed prophylactic therapies for hemophilia.
  • ICH management in vWD requires individualized treatment with factor concentrates and antifibrinolytics.

Conclusions:

  • Hemophilia and vWD predispose patients to life-threatening CNS bleeds.
  • Prophylactic regimens and early hematologist consultation are vital for prevention.
  • Further research is needed on Emicizumab for on-demand ICH treatment in hemophilia.